MedPath

江西捷众制药有限公司

Ownership
-
Established
2005-08-16
Employees
-
Market Cap
-
Website
www.jiezhongzhiyao.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

13

NMPA:13

Drug Approvals

Compound Benzoic Acid and Camphor SolutionI

Product Name
复方水杨酸樟碘溶液Ⅰ
Approval Number
国药准字H36022102
Approval Date
Jun 9, 2020
NMPA

Domperidone Tablets

Product Name
多潘立酮片
Approval Number
国药准字H20033864
Approval Date
Jun 9, 2020
NMPA

Furazolidone Tablets

Product Name
呋喃唑酮片
Approval Number
国药准字H36021683
Approval Date
Sep 10, 2019
NMPA

Vitamin C Tablets

Product Name
维生素C片
Approval Number
国药准字H36021607
Approval Date
Sep 10, 2019
NMPA

Berberine Hydrochloride Tablets

Product Name
盐酸小檗碱片
Approval Number
国药准字H36021682
Approval Date
Sep 10, 2019
NMPA

Oryzanol Tablets

Product Name
谷维素片
Approval Number
国药准字H36021677
Approval Date
Sep 10, 2019
NMPA

Inosine Tablets

Product Name
肌苷片
Approval Number
国药准字H36021596
Approval Date
Sep 10, 2019
NMPA

Metronidazole Tablets

Product Name
甲硝唑片
Approval Number
国药准字H36021679
Approval Date
Sep 10, 2019
NMPA

Ribavirin Tablets

Product Name
利巴韦林片
Approval Number
国药准字H19993657
Approval Date
Sep 10, 2019
NMPA

Compound sulfamethoxazole Tablets

Product Name
复方磺胺甲噁唑片
Approval Number
国药准字H36021676
Approval Date
Sep 10, 2019
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.